does glucagon actually matter or is it forum lore at this point
Something I noticed reading old threads that I have not seen said out loud.
The advice on TRIUMPH in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with the same confidence.
I have listed what I think the current consensus is below. Correct me — that is the point of posting it.
best — the order this archive was captured in
The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
the 0.5mg arm is different from 1.0mg, results do not transfer
retatrutide is not approved anywhere for human use, posts must not read as instructions
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
the 0.25mg arm is different from 15mg, results do not transfer
retatrutide is not approved anywhere for human use, posts must not read as instructions
triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual
Flair changed to match the content. Read the sidebar before posting next time and we are square.
This is correct. Triple agonism is genuinely different.
That is net peptide content, not purity. Different number, different meaning.
the dosing is steep, the sulphur burps reports are real, and nobody knows the human safety yet
the weight curves are unusually steep, which makes predicting individual response harder
the weight curves are unusually steep, which makes predicting individual response harder
Adding to this: TRIUMPH is doing more work than the comment implies.
the glucagon component changes the side effect profile, not just the efficacy
Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.
the dosing is steep, the constipation reports are real, and nobody knows the human safety yet
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual
- 1the dosing is steep, the sulphur burps reports are real, and nobody knows…7 comments in this branch · started by u/baseline_drifter
- 2nope. mine was the opposite.6 comments in this branch · started by u/matias_falk